Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: wvalx who wrote (19507)	3/9/1999 9:38:00 PM
From: Little Gorilla	Read Replies (1) \| Respond to of 23519

>>he uses the term "was" like MUSE is dead and gone<< I noticed that too. Maybe it's a good sign of new things to come.

To: wvalx who wrote (19507)	3/9/1999 9:44:00 PM
From: wvalx	Read Replies (2) \| Respond to of 23519

Ok thinking about the term clitoris cream... Here's an ignorant question, how do pharmas come up with names for their drugs? How soon do they come up with one? While submitting approval for Phase I? Maybe, while we wait for up to 2 years, we can have a little contest to come up with one and use it instead of "clitoris cream", maybe even submit it to Vivus....their IR/PR dept. needs help anyways. Can anyone also, briefly, run down the 3 phases and usual timelines?

To: wvalx who wrote (19507)	3/9/1999 9:48:00 PM
From: RT	Respond to of 23519

wvalx, I think the idiot was trying to do a comparison of Muse vs Clit cream, but of course he managed to bad mouth our only product in the process. Will someone please donate a muzzle to shut the dumb ass up before it's too late.. RT